Canaccord Adams reiterates a 'Buy' on HeartWare International (Nasdaq: HTWR), raises price target to $42.

Canaccord analyst says, "Growth initiatives ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE